AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million
LONDON (Reuters) – British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and bipolar disease, to Luye Pharma Group for $538 million, as…